In the last 12 months, insiders at Aurinia Pharmaceuticals Inc. ($AUPH) filed 115 transactions with the SEC: 18 open-market purchases totaling $49,813,932 and 30 sales totaling $8,832,733. Net insider sentiment: net buying.
Aurinia Pharmaceuticals Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- TANG KEVIN (Not found) — 18 transactions totaling $49,813,932
- Greenleaf Peter (Chief Executive Officer) — 14 transactions totaling $8,553,525
- Robertson Stephen P. (EVP, General Counsel) — 14 transactions totaling $3,133,018
- Miller Joseph M (Chief Financial Officer) — 14 transactions totaling $2,875,133
- Donley Matthew Maxwell (Chief Operating Officer) — 11 transactions totaling $2,729,866
View all SEC Filings for Aurinia Pharmaceuticals Inc. (AUPH).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | Keenan Greg | SVP, Chief Medical Officer | F | Common Stock | 8069 | $14.32 | 154,449.0000 | 138,959,000 | 4.96% | 0.01% |
| March 2, 2026 | Robertson Stephen P. | EVP, General Counsel | F | Common Stock | 36525 | $14.21 | 505,861.0000 | 138,959,000 | 6.73% | 0.03% |
| Feb. 27, 2026 | Robertson Stephen P. | EVP, General Counsel | A | Common Stock | 59090 | $0.00 | 542,386.0000 | 138,959,000 | 12.23% | 0.04% |
| Feb. 27, 2026 | Keenan Greg | SVP, Chief Medical Officer | A | Employee Stock Option (right to buy) | 67870 | $0.00 | 67,870.0000 | 138,959,000 | 9999.99% | 0.05% |
| Feb. 27, 2026 | Keenan Greg | SVP, Chief Medical Officer | A | Common Stock | 40586 | $0.00 | 162,518.0000 | 138,959,000 | 33.29% | 0.03% |
| Feb. 27, 2026 | Greenleaf Peter | Chief Executive Officer | A | Employee Stock Option (right to buy) | 328424 | $0.00 | 328,424.0000 | 138,959,000 | 9999.99% | 0.24% |
| March 2, 2026 | Greenleaf Peter | Chief Executive Officer | F | Common Stock | 100890 | $14.21 | 1,840,379.0000 | 138,959,000 | 5.20% | 0.07% |
| Feb. 27, 2026 | Greenleaf Peter | Chief Executive Officer | A | Common Stock | 196403 | $0.00 | 1,941,269.0000 | 138,959,000 | 11.26% | 0.14% |
| Feb. 27, 2026 | Donley Matthew Maxwell | Chief Operating Officer | A | Employee Stock Option (right to buy) | 97256 | $0.00 | 97,256.0000 | 138,959,000 | 9999.99% | 0.07% |
| March 2, 2026 | Donley Matthew Maxwell | Chief Operating Officer | F | Common Stock | 40761 | $14.21 | 680,299.0000 | 138,959,000 | 5.65% | 0.03% |
| Feb. 27, 2026 | Robertson Stephen P. | EVP, General Counsel | A | Employee Stock Option (right to buy) | 98813 | $0.00 | 98,813.0000 | 138,959,000 | 9999.99% | 0.07% |
| Feb. 27, 2026 | Miller Joseph M | Chief Financial Officer | A | Employee Stock Option (right to buy) | 95700 | $0.00 | 95,700.0000 | 138,959,000 | 9999.99% | 0.07% |
| March 2, 2026 | Miller Joseph M | Chief Financial Officer | F | Common Stock | 37511 | $14.21 | 576,421.0000 | 138,959,000 | 6.11% | 0.03% |
| Feb. 27, 2026 | Miller Joseph M | Chief Financial Officer | A | Common Stock | 57229 | $0.00 | 613,932.0000 | 138,959,000 | 10.28% | 0.04% |
| Feb. 27, 2026 | Donley Matthew Maxwell | Chief Operating Officer | A | Common Stock | 58160 | $0.00 | 721,060.0000 | 138,959,000 | 8.77% | 0.04% |
| March 3, 2026 | TANG KEVIN | Not found | P | Common Shares | 184208 | $14.22 | 12,229,500.0000 | 138,959,000 | 1.53% | 0.13% |
| March 2, 2026 | TANG KEVIN | Not found | P | Common Shares | 115792 | $14.21 | 12,045,292.0000 | 138,959,000 | 0.97% | 0.08% |
| March 2, 2026 | TANG KEVIN | Not found | P | Common Shares | 83561 | $14.33 | 11,929,500.0000 | 138,959,000 | 0.71% | 0.06% |
| Feb. 27, 2026 | TANG KEVIN | Not found | P | Common Shares | 1600 | $14.38 | 11,845,939.0000 | 138,959,000 | 0.01% | 0.00% |
| Feb. 27, 2026 | TANG KEVIN | Not found | P | Common Shares | 214839 | $14.12 | 11,844,339.0000 | 138,959,000 | 1.85% | 0.15% |
| Feb. 27, 2026 | TANG KEVIN | Not found | P | Common Shares | 300000 | $13.90 | 11,629,500.0000 | 138,959,000 | 2.65% | 0.22% |
| Feb. 20, 2026 | Donley Matthew Maxwell | Chief Operating Officer | F | Common Stock | 32901 | $14.40 | 662,900.0000 | 138,959,000 | 4.73% | 0.02% |
| Feb. 20, 2026 | Greenleaf Peter | Chief Executive Officer | F | Common Stock | 100171 | $14.40 | 1,744,866.0000 | 138,959,000 | 5.43% | 0.07% |
| Feb. 20, 2026 | Miller Joseph M | Chief Financial Officer | F | Common Stock | 32424 | $14.40 | 556,703.0000 | 138,959,000 | 5.50% | 0.02% |
| Feb. 20, 2026 | Robertson Stephen P. | EVP, General Counsel | F | Common Stock | 34638 | $14.40 | 483,296.0000 | 138,959,000 | 6.69% | 0.02% |
| Feb. 2, 2026 | Keenan Greg | SVP, Chief Medical Officer | F | Common Stock | 11552 | $14.53 | 121,932.0000 | 138,959,000 | 8.65% | 0.01% |
| Jan. 2, 2026 | Robertson Stephen P. | EVP, General Counsel | A | Common Stock | 48558 | $0.00 | 557,434.0000 | 138,959,000 | 9.54% | 0.03% |
| Jan. 2, 2026 | Miller Joseph M | Chief Financial Officer | F | Common Stock | 40161 | $15.95 | 589,127.0000 | 138,959,000 | 6.38% | 0.03% |
| Jan. 2, 2026 | Miller Joseph M | Chief Financial Officer | A | Common Stock | 49038 | $0.00 | 626,399.0000 | 138,959,000 | 8.49% | 0.04% |
| Jan. 2, 2026 | Donley Matthew Maxwell | Chief Operating Officer | F | Common Stock | 42787 | $15.95 | 695,801.0000 | 138,959,000 | 5.79% | 0.03% |
| Jan. 2, 2026 | Donley Matthew Maxwell | Chief Operating Officer | A | Common Stock | 54166 | $0.00 | 734,631.0000 | 138,959,000 | 7.96% | 0.04% |
| Jan. 2, 2026 | Robertson Stephen P. | EVP, General Counsel | F | Common Stock | 40385 | $15.95 | 517,934.0000 | 138,959,000 | 7.23% | 0.03% |
| Jan. 2, 2026 | Greenleaf Peter | Chief Executive Officer | F | Common Stock | 113169 | $15.95 | 1,845,037.0000 | 138,959,000 | 5.78% | 0.08% |
| Jan. 2, 2026 | Greenleaf Peter | Chief Executive Officer | A | Common Stock | 165384 | $0.00 | 1,954,329.0000 | 138,959,000 | 9.24% | 0.12% |
| Nov. 21, 2025 | Bailey Jeffrey Allen | Director | F | Common Shares | 2716 | $15.68 | 22,775.0000 | 138,959,000 | 10.65% | 0.00% |
| Nov. 21, 2025 | Johnson Craig A | Director | F | Common Shares | 6039 | $15.68 | 14,592.0000 | 138,959,000 | 29.27% | 0.00% |
| Aug. 1, 2025 | Keenan Greg | Chief Medical Officer | S | Common Stock | 20000 | $10.50 | 133,484.0000 | 146,194,000 | 13.03% | 0.01% |
| Aug. 1, 2025 | TANG KEVIN | Not found | P | Common Shares | 1000000 | $10.12 | 11,029,500.0000 | 146,194,000 | 9.97% | 0.68% |
| Aug. 5, 2025 | TANG KEVIN | Not found | P | Common Shares | 200000 | $11.68 | 11,329,500.0000 | 146,194,000 | 1.80% | 0.14% |
| Aug. 4, 2025 | TANG KEVIN | Not found | P | Common Shares | 100000 | $11.34 | 11,129,500.0000 | 146,194,000 | 0.91% | 0.07% |
| May 16, 2025 | Johnson Craig A | Director | A | Director Stock Option (right to buy) | 37485 | $0.00 | 37,485.0000 | 146,194,000 | 9999.99% | 0.03% |
| May 16, 2025 | Goetz Kathleen | Director | A | Director Stock Option (right to buy) | 63724 | $0.00 | 63,724.0000 | 146,194,000 | 9999.99% | 0.04% |
| May 16, 2025 | Nova Tina Susan | Director | A | Director Stock Option (right to buy) | 63724 | $0.00 | 63,724.0000 | 146,194,000 | 9999.99% | 0.04% |
| May 16, 2025 | Bailey Jeffrey Allen | Director | A | Director Stock Option (right to buy) | 37485 | $0.00 | 37,485.0000 | 146,194,000 | 9999.99% | 0.03% |
| March 7, 2025 | Keenan Greg | Chief Medical Officer | S | Common Stock | 8305 | $8.23 | 153,484.0000 | 146,194,000 | 5.13% | 0.01% |
| March 3, 2025 | Donley Matthew Maxwell | Chief Operating Officer | A | Common Stock | 135567 | $0.00 | 805,358.0000 | 146,194,000 | 20.24% | 0.09% |
| Feb. 28, 2025 | Greenleaf Peter | Chief Executive Officer | A | Common Stock | 290728 | $0.00 | 1,815,780.0000 | 146,194,000 | 19.06% | 0.20% |
| March 3, 2025 | Greenleaf Peter | Chief Executive Officer | A | Common Stock | 333705 | $0.00 | 2,149,485.0000 | 146,194,000 | 18.38% | 0.23% |
| March 3, 2025 | Greenleaf Peter | Chief Executive Officer | S | Common Stock | 195593 | $8.00 | 1,953,892.0000 | 146,194,000 | 9.10% | 0.13% |
| March 4, 2025 | Greenleaf Peter | Chief Executive Officer | S | Common Stock | 164947 | $7.92 | 1,788,945.0000 | 146,194,000 | 8.44% | 0.11% |
| Feb. 28, 2025 | Greenleaf Peter | Chief Executive Officer | A | Employee Stock Option (right to buy) | 443973 | $0.00 | 443,973.0000 | 146,194,000 | 9999.99% | 0.30% |
| Feb. 28, 2025 | Keenan Greg | Chief Medical Officer | A | Common Stock | 62583 | $0.00 | 174,028.0000 | 146,194,000 | 56.16% | 0.04% |
| March 3, 2025 | Keenan Greg | Chief Medical Officer | S | Common Stock | 12239 | $8.00 | 161,789.0000 | 146,194,000 | 7.03% | 0.01% |
| Feb. 28, 2025 | Keenan Greg | Chief Medical Officer | A | Employee Stock Option (right to buy) | 95570 | $0.00 | 95,570.0000 | 146,194,000 | 9999.99% | 0.07% |
| Feb. 28, 2025 | Miller Joseph M | Chief Financial Officer | A | Common Stock | 81457 | $0.00 | 580,663.0000 | 146,194,000 | 16.32% | 0.06% |
| March 3, 2025 | Miller Joseph M | Chief Financial Officer | A | Common Stock | 114711 | $0.00 | 695,374.0000 | 146,194,000 | 19.76% | 0.08% |
| March 3, 2025 | Miller Joseph M | Chief Financial Officer | S | Common Stock | 61859 | $8.00 | 633,515.0000 | 146,194,000 | 8.90% | 0.04% |
| March 4, 2025 | Miller Joseph M | Chief Financial Officer | S | Common Stock | 56154 | $7.92 | 577,361.0000 | 146,194,000 | 8.86% | 0.04% |
| Feb. 28, 2025 | Miller Joseph M | Chief Financial Officer | A | Employee Stock Option (right to buy) | 124393 | $0.00 | 124,393.0000 | 146,194,000 | 9999.99% | 0.09% |
| Feb. 28, 2025 | Robertson Stephen P. | EVP, General Counsel | A | Common Stock | 84106 | $0.00 | 529,349.0000 | 146,194,000 | 18.89% | 0.06% |
| March 3, 2025 | Robertson Stephen P. | EVP, General Counsel | A | Common Stock | 102406 | $0.00 | 631,755.0000 | 146,194,000 | 19.35% | 0.07% |
| March 3, 2025 | Robertson Stephen P. | EVP, General Counsel | S | Common Stock | 64872 | $8.00 | 566,883.0000 | 146,194,000 | 10.27% | 0.04% |
| March 4, 2025 | Robertson Stephen P. | EVP, General Counsel | S | Common Stock | 57607 | $7.92 | 509,276.0000 | 146,194,000 | 10.16% | 0.04% |
| Feb. 28, 2025 | Robertson Stephen P. | EVP, General Counsel | A | Employee Stock Option (right to buy) | 128438 | $0.00 | 128,438.0000 | 146,194,000 | 9999.99% | 0.09% |
| Feb. 28, 2025 | Donley Matthew Maxwell | Chief Operating Officer | A | Common Stock | 82781 | $0.00 | 669,791.0000 | 146,194,000 | 14.10% | 0.06% |
| March 3, 2025 | Donley Matthew Maxwell | Chief Operating Officer | S | Common Stock | 65902 | $8.00 | 739,456.0000 | 146,194,000 | 8.18% | 0.05% |
| March 4, 2025 | Donley Matthew Maxwell | Chief Operating Officer | S | Common Stock | 58991 | $7.92 | 680,465.0000 | 146,194,000 | 7.98% | 0.04% |
| Feb. 28, 2025 | Donley Matthew Maxwell | Chief Operating Officer | A | Employee Stock Option (right to buy) | 126416 | $0.00 | 126,416.0000 | 146,194,000 | 9999.99% | 0.09% |
| Feb. 28, 2025 | TANG KEVIN | Not found | P | Common Shares | 399280 | $7.85 | 8,828,780.0000 | 146,194,000 | 4.74% | 0.27% |
| March 3, 2025 | TANG KEVIN | Not found | P | Common Shares | 100720 | $7.97 | 8,929,500.0000 | 146,194,000 | 1.14% | 0.07% |
| March 3, 2025 | TANG KEVIN | Not found | P | Common Shares | 351962 | $8.02 | 9,281,462.0000 | 146,194,000 | 3.94% | 0.24% |
| March 4, 2025 | TANG KEVIN | Not found | P | Common Shares | 148038 | $8.00 | 9,429,500.0000 | 146,194,000 | 1.59% | 0.10% |
| March 4, 2025 | TANG KEVIN | Not found | P | Common Shares | 500000 | $7.92 | 9,929,500.0000 | 146,194,000 | 5.30% | 0.34% |
| March 4, 2025 | TANG KEVIN | Not found | P | Common Shares | 100000 | $8.09 | 10,029,500.0000 | 146,194,000 | 1.01% | 0.07% |
| Dec. 5, 2024 | TANG KEVIN | Not found | P | Common Shares | 300000 | $8.91 | 7,529,500.0000 | 145,651,000 | 4.15% | 0.21% |
| Dec. 6, 2024 | TANG KEVIN | Not found | P | Common Shares | 400000 | $9.01 | 7,929,500.0000 | 145,651,000 | 5.31% | 0.27% |
| Dec. 9, 2024 | TANG KEVIN | Not found | P | Common Shares | 500000 | $9.09 | 8,429,500.0000 | 145,651,000 | 6.31% | 0.34% |
| Nov. 21, 2024 | Leversage Jill | Director | A | Common Shares | 12135 | $0.00 | 25,053.0000 | 145,651,000 | 93.94% | 0.01% |
| Nov. 21, 2024 | Leversage Jill | Director | A | Director Stock Option (right to buy) | 18641 | $0.00 | 18,641.0000 | 145,651,000 | 9999.99% | 0.01% |
| Nov. 21, 2024 | Johnson Craig A | Director | A | Common Shares | 20631 | $0.00 | 20,631.0000 | 145,651,000 | 9999.99% | 0.01% |
| Nov. 21, 2024 | Johnson Craig A | Director | A | Director Stock Option (right to buy) | 31688 | $0.00 | 31,688.0000 | 145,651,000 | 9999.99% | 0.02% |
| Nov. 21, 2024 | Bailey Jeffrey Allen | Director | A | Common Shares | 12135 | $0.00 | 25,491.0000 | 145,651,000 | 90.86% | 0.01% |
| Nov. 21, 2024 | Bailey Jeffrey Allen | Director | A | Director Stock Option (right to buy) | 18641 | $0.00 | 18,641.0000 | 145,651,000 | 9999.99% | 0.01% |
| Nov. 21, 2024 | Jayne David R.W. | Director | A | Director Stock Option (right to buy) | 18641 | $0.00 | 18,641.0000 | 145,651,000 | 9999.99% | 0.01% |
| Nov. 21, 2024 | Jayne David R.W. | Director | A | Common Shares | 12135 | $0.00 | 56,499.0000 | 145,651,000 | 27.35% | 0.01% |
| Nov. 21, 2024 | Smith Karen L. | Director | A | Common Shares | 12135 | $0.00 | 24,807.0000 | 145,651,000 | 95.76% | 0.01% |
| Nov. 21, 2024 | Smith Karen L. | Director | A | Director Stock Option (right to buy) | 18641 | $0.00 | 18,641.0000 | 145,651,000 | 9999.99% | 0.01% |
| Nov. 11, 2024 | Smith Karen L. | Director | S | Common Stock | 5241 | $8.43 | 12,672.0000 | 145,651,000 | 29.26% | 0.00% |
| Nov. 8, 2024 | Smith Karen L. | Director | M | Restricted Stock Units | 17913 | $0.00 | 0.0000 | 145,651,000 | 100.00% | 0.01% |
| Nov. 8, 2024 | Smith Karen L. | Director | M | Common Stock | 17913 | $0.00 | 17,913.0000 | 145,651,000 | 9999.99% | 0.01% |
| Nov. 8, 2024 | Bailey Jeffrey Allen | Director | M | Restricted Stock Units | 17913 | $0.00 | 0.0000 | 145,651,000 | 100.00% | 0.01% |
| Nov. 11, 2024 | Bailey Jeffrey Allen | Director | S | Common Stock | 4557 | $8.43 | 13,356.0000 | 145,651,000 | 25.44% | 0.00% |
| Nov. 8, 2024 | Bailey Jeffrey Allen | Director | M | Common Stock | 17913 | $0.00 | 17,913.0000 | 145,651,000 | 9999.99% | 0.01% |
| Aug. 6, 2024 | Habig Scott Michael | Chief Commercial Officer | S | Common Stock | 18249 | $5.31 | 456,338.0000 | 143,236,000 | 3.85% | 0.01% |
| May 21, 2024 | MacKay-Dunn R. Hector | Director | S | Common Stock | 5630 | $5.74 | 18,595.0000 | 143,236,000 | 23.24% | 0.00% |
| May 21, 2024 | Balakrishnan Brinda | Director | S | Common Stock | 520 | $5.74 | 17,523.0000 | 143,236,000 | 2.88% | 0.00% |
| May 21, 2024 | Billen Daniel | Director | S | Common Stock | 5252 | $5.74 | 28,141.0000 | 143,236,000 | 15.73% | 0.00% |
| May 21, 2024 | Jayne David R.W. | Director | S | Common Stock | 4946 | $5.74 | 44,364.0000 | 143,236,000 | 10.03% | 0.00% |
| May 21, 2024 | Leversage Jill | Director | S | Common Stock | 5610 | $5.74 | 12,918.0000 | 143,236,000 | 30.28% | 0.00% |
| March 6, 2024 | Robertson Stephen P. | EVP, General Counsel | S | Common Stock | 57745 | $5.60 | 443,824.0000 | 143,236,000 | 11.51% | 0.04% |
| March 6, 2024 | Greenleaf Peter | Chief Executive Officer | S | Common Stock | 126981 | $5.60 | 1,522,114.0000 | 143,236,000 | 7.70% | 0.09% |
| March 6, 2024 | Miller Joseph M | Chief Financial Officer | S | Common Stock | 34811 | $5.60 | 495,928.0000 | 143,236,000 | 6.56% | 0.02% |
| March 6, 2024 | Donley Matthew Maxwell | EVP, Ops & Strategy | S | Common Stock | 40665 | $5.51 | 584,072.0000 | 143,236,000 | 6.51% | 0.03% |
| March 6, 2024 | Habig Scott Michael | Chief Commercial Officer | S | Common Stock | 17777 | $5.60 | 474,587.0000 | 143,236,000 | 3.61% | 0.01% |
| Feb. 27, 2024 | Knappertz Volker | EVP, Research and Development | S | Common Stock | 4930 | $6.10 | 319,128.0000 | 143,236,000 | 1.52% | 0.00% |
| Feb. 20, 2024 | Knappertz Volker | EVP, Research and Development | S | Common Stock | 25146 | $5.48 | 324,058.0000 | 143,236,000 | 7.20% | 0.02% |
| Feb. 20, 2024 | Habig Scott Michael | Chief Commercial Officer | A | Common Stock | 195512 | $0.00 | 508,231.0000 | 143,236,000 | 62.52% | 0.14% |
| Feb. 20, 2024 | Habig Scott Michael | Chief Commercial Officer | S | Common Stock | 15867 | $5.48 | 492,364.0000 | 143,236,000 | 3.12% | 0.01% |
| Feb. 20, 2024 | Donley Matthew Maxwell | EVP, Ops & Strategy | A | Common Stock | 216666 | $0.00 | 624,737.0000 | 143,236,000 | 53.10% | 0.15% |
| March 2, 2023 | Greenleaf Peter | Chief Executive Officer | S | Common Stock | 33047 | $8.78 | 982,671.0000 | 141,915,000 | 3.25% | 0.02% |
| March 2, 2023 | Miller Joseph M | Chief Financial Officer | S | Common Stock | 11398 | $8.78 | 331,112.0000 | 141,915,000 | 3.33% | 0.01% |
| March 2, 2023 | Robertson Stephen P. | EVP, General Counsel | S | Common Stock | 19644 | $8.78 | 303,122.0000 | 141,915,000 | 6.09% | 0.01% |
| Feb. 20, 2024 | Greenleaf Peter | Chief Executive Officer | A | Common Stock | 661538 | $0.00 | 1,649,095.0000 | 143,236,000 | 66.99% | 0.46% |
| Feb. 20, 2024 | Robertson Stephen P. | EVP, General Counsel | A | Common Stock | 194230 | $0.00 | 501,569.0000 | 143,236,000 | 63.20% | 0.14% |
| Feb. 20, 2024 | Miller Joseph M | Chief Financial Officer | A | Common Stock | 196153 | $0.00 | 530,739.0000 | 143,236,000 | 58.63% | 0.14% |